Table 2.
BBFC (n=1,077) | Brinzolamide (n=646) | Brimonidine (n=627) | |
---|---|---|---|
Ocular hyperemia | 36 (3.3%) | 4 (0.6%) | 8 (1.7%) |
Eye pain | 27 (2.5%) | 11 (1.7%) | 5 (0.8%) |
Dysgeusia | 39 (3.6%) | 42 (6.5%) | 3 (0.3%) |
Blurred vision | 41 (3.8%) | 31 (4.8%) | 4 (0.4%) |
Dry mouth | 31 (2.8%) | 2 (0.3%) | 20 (3.2%) |
Conjunctivitis | 16 (4.8%) | 0 | 8 (1.2%) |
Eye pruritus | 25 (2.3%) | 8 (1.2%) | 4 (1.1%) |
Allergic conjunctivitis | 37 (2.4%) | 2 (0.3%) | 10 (1.5%) |
Eye allergy | 22 (2.2%) | 0 | 7 (1.1%) |
Eye irritation | 30 (2.7%) | 10 (1.5%) | 13 (2.1%) |
Conjunctival hyperemia | 17 (1.5%) | 8 (1.2%) | 9 (1.4%) |
Dry eyes | 7 (1.1%) | 5 (0.8%) | 10 (1.6%) |
Abbreviation: BBFC, brinzolamide 1% and brimonidine 0.2% fixed combination.